Summary In women, but not men, lower 25-hydroxyvitamin D [25(OH)D] levels were associated with impaired performance on two lower extremity function tests in both cross-sectional and prospective analyses. Introduction Preserved physical function may explain how 25(OH)D supplementation reduces falls and fractures. Methods A total of 1,065 community-dwelling men and women (mean age 74.6 years) with 25(OH)D levels and performance on timed up and go (TUG) and timed chair stand (TCS) were seen in 1997-1999; 769 (72%) participants returned for follow-up. Associations were examined using generalized linear models. Results 25(OH)D levels were higher in men than women, but the prevalence of vitamin D insufficiency defined as 25 (OH)D <75 nmol/L was 14%. There were no baseline sex differences in TUG or TCS. However, after 2.5 years, decline in TCS and TUG was greater in women than men (11% vs. 3%; p<0.001). Women in the lowest 25(OH)D quartile (<80 nmol/L) compared to the highest quartile had an accelerated rate of functional decline on the TUG and TCS independent of covariates. No significant associations were seen in men.
Introduction
Vitamin D maintains serum calcium levels by increasing intestinal calcium and phosphorous absorption. Vitamin D stimulates stem cells in the bone to become mature osteoclasts, which mobilize calcium from the bone into the circulation for bone mineralization [1] . 25-Hydroxyvitamin D [25(OH)D] levels decline with age due to several mechanisms including decreased ultraviolet light exposure, decreased vitamin D 3 skin conversion, decreased oral intake, and decreased hydroxylation in the liver. Serum 25(OH)D concentrations vary with latitude, season, race, age, and dietary intake [2] . Prevalence of vitamin D deficiency/insufficiency ranges between 7% and 80% depending on the defined cutpoint [3] [4] [5] [6] [7] [8] [9] [10] . The suggested minimal 25(OH)D levels whereby parathyroid hormone (PTH) secretion is minimized and intestinal calcium absorption is maximized range between 40 and 122 nmol/L [11] [12] [13] [14] .
Several studies have examined the effects of vitamin D on fractures and falls. In a metaanalysis, Bischoff-Ferrari et al. [15] found that the usual recommended dose of vitamin D (400-600 IU daily) was ineffective for reducing fractures, but fracture prevention was demonstrated in persons taking more than 800 IU daily, suggesting that higher doses of vitamin D intake are necessary for fracture prevention. Although most of the protective effects of vitamin D on fractures have been attributed to its effect on bone mineral density, vitamin D may also mediate fracture risk by decreasing falls. Broe and colleagues randomly assigned 124 nursing home residents to four vitamin D supplement doses for 5 months and found that participants randomized to the 800-IU group had a 72% lower incidence rate of falls compared to participants on placebo [16] . Additionally, a metaanalysis by Bischoff-Ferrari which included five randomized controlled trials of 1,237 participants showed that subjects taking vitamin D supplements were significantly less likely to have at least one fall (relative risk reduction 22%) [17] . A similar metaanalysis by Jackson and colleagues also showed that the pooled relative risk for preventing falls was 0.88 (95%CI=0.78-1.00) in the vitamin D-supplemented group compared to placebo [18] .
In addition to the benefits on bone health and falls, vitamin D has a less well-known effect on muscle metabolism. Knockout mice without vitamin D receptors (VDR) demonstrated altered muscle development [19] , and prolonged vitamin D deficiency in adults has been associated with severe muscle weakness that improved after vitamin D supplementation [20] [21] [22] . Some epidemiologic studies have shown a correlation between low 25(OH) D levels and physical performance [23] [24] [25] [26] [27] , while other studies found no association [28] . Results of vitamin D supplementation in clinical trials have also been contradictory. Some trials observed no effect of vitamin D supplements on muscle strength [23, 29, 30] or disability in activities of daily living [31] , while a beneficial effect on muscle function was observed by others [32, 33] . The majority of these studies were small and examined mostly women with very low levels of 25(OH)D. None of these studies evaluated the association of 25(OH)D levels with muscle strength in a population with high 25(OH)D levels or a low prevalence of vitamin D deficiency. The present study of community-dwelling men and women is the largest prospective study to examine sex-specific differences between serum 25(OH)D insufficiency and declining performance on physical function tests.
Materials and methods

Study population
The Rancho Bernardo Study (RBS) is a longitudinal observational cohort study based in a southern California community. Eighty-two percent of the adults who were at least 30 years of age were enrolled in the RBS from 1972 to 1974. A high proportion of the surviving participants have been followed for various exposures and common diseases using annual mailers and clinical evaluations repeated approximately every 4 years.
For the current analysis, we studied 1,065 communitydwelling ambulatory Caucasian men and women who had serum 25(OH)D assays and physical function tests measured in 1997-1999. Of these participants, 769 (72%) returned for a clinic visit in 1999-2002, an average of 2.5 years later (median 2.5 years, range 0.4 to 5 years) and had repeat physical function measures. Of the 237 subjects who did not participate in the follow-up visit, 99 (42%) had died. Participants gave written informed consent. The University of California San Diego Institutional Review Board approved the study.
Covariates
At both visits, participants completed a self-administered questionnaire that included personal and family medical history (including fractures), medication and supplement use, and lifestyle factors (physical activity, smoking, and alcohol intake). Baseline physical activity level was ascertained from participants' response to "Do you exercise three or more times a week?". A registered nurse confirmed medication use by examining pills and prescriptions brought to the clinic. Participants were asked if they used calcium or vitamin D supplements; use of each supplement was categorized yes/no. Height and weight were measured in the clinic with participants wearing light clothing and no shoes. Body mass index (BMI) was calculated as body weight (in kilograms) divided by height (in square meters). Comorbidities such as history of hypertension, diabetes, cardiovascular disease, congestive heart failure, and stroke were obtained by self-report.
Blood samples
At the baseline visit, blood for 25(OH)D was obtained between 8 and 12 A.M. from fasting participants in tubes that were protected from sunlight. Serum was stored at −70°C within 30 min of processing. Serum 25(OH)D levels were analyzed by a competitive protein-binding assay (CPBA) in the vitamin D research laboratory of Dr. Michael Holick (Boston University), as described by Chen et al. [34] . The intraassay and interassay coefficients of variation were 8% and 10%, respectively. The limit of detection was 12.5 nmol/L, and the reference range was 25-130 nmol/L. The results obtained from the CPBA have good agreement with those obtained by liquid chromatography/mass spectrometry [35] . Intact PTH values were determined in the same laboratory using a chemilumines-cence assay kit (Nichols Institute Diagnostics, San Juan Capistrano, CA, USA). The assay has both intraassay and interassay coefficients of variation of 6% and a reference of 10-65 ng/L. Serum creatinine levels were measured by Smith Kline Beecham clinical laboratories. Creatinine clearance was calculated by the modified Cockcroft-Gault formula: [140− age (in years)] multiplied by weight (in kilograms) divided by [72×serum creatinine (in milligrams per deciliter)] and multiplied by 0.85 (correction factor for females) [36] . Creatinine clearance levels <30 mg/mL were considered to represent "moderate" or "severe" renal insufficiency.
Physical function measures
At both visits, lower extremity function was assessed using the timed up and go test (TUG) and timed chair stands (TCS); upper extremity strength was assessed using grip strength (GS) test.
TUG measures the amount of time it takes to rise from a chair, walk 3 m, and return to a sitting position. Two trials of the TUG were performed by each participant and recorded to the tenth of a second. Increasing time to perform these activities reflect worse performance and a decline in function at the follow-up visit. Overall, 96% (n= 1,030) of the participants were able to complete this test.
For the TCS, participants were seated with their arms folded across their chests in a straight-backed chair and asked to stand up and sit down as quickly as possible five times without stopping or using their arms to push off. The time to complete the TCS from initial seating to final standing position was recorded in seconds. Increasing time to complete the TCS reflect poorer performance and a decline in function at the follow-up visit. Overall, 90% (n= 962) of the participants were able to perform the TCS.
GS was measured in each hand using a Jamar dynamometer. A trained examiner adjusted the handle so that the dynamometer was held comfortably in the hand with the elbow flexed at 90°and the forearm parallel to the floor. The dynamometer was squeezed maximally while simultaneously lowering the arm on a 3-s count. GS was recorded to the nearest 0.5 kg. Higher values reflect better performance. Approximately 95% (n=1,020) of the participants were able to complete the GS test.
Statistical analysis
Participant baseline characteristics were summarized using means (±standard deviation [SD]) for continuous variables and counts and percentages for categorical variables. For continuous variables with normal distributions, Student's t tests were used. Differences in categorical variables were examined using chi-square test. Vitamin D deficiency was defined as 25(OH)D levels less than 50 nmol/L, while vitamin D insufficiency was defined as 25(OH)D levels less than 75 nmol/L. Serum 25(OH)D concentrations were analyzed by sex-specific quartiles. The presence of a nonlinear (quadratic) effect of 25(OH)D concentration was examined but was not apparent, so only the linear associations were modeled.
The average of the two TUG results are presented. The average GS was analyzed to reduce confounding due to hand dominance. Separate analyses were performed for the each different physical function outcome (TCS, TUG, and GS). Percent change in physical function was calculated as the difference between baseline and follow-up values divided by baseline physical performance.
Generalized linear models were used to examine the independent association between 25(OH)D levels and each measure of physical function. Known factors associated with 25(OHD levels and/or physical function were examined for inclusion in multivariate models. Covariates with a p value <0.10 in the bivariate analysis were added to the final model. Potential confounders included in the multivariate models were age, sex, BMI, baseline physical activity level, alcohol use, and estrogen use (only in women). Initially, analyses combining the two sexes showed a significant interaction (p<0.05) between 25(OH) D levels, physical function, and sex. Therefore, all analyses were stratified by sex. All analyses were performed using SAS version 8.2 (SAS Institute, Cary NC, USA). All statistical tests were two-tailed, and statistical significance was defined as a p value <0.05.
Results
Sex-specific baseline characteristics of the 1,065 participants are shown in Table 1 . Their mean±SD age was 74.6± 10.3 years; 61% were women and 98% were Caucasian. About 72% exercised three or more times per week; 50% were previous smokers, but only 4.5% smoked at baseline.
In this cohort, 58.5% of women and 21.9% of men were taking calcium supplements, while fewer participants were taking vitamin D supplements (28.6% women and 9.3% men). Even though three times more women were taking vitamin D supplements, the mean serum 25(OH)D concentrations were higher in men (107.6±29.2 nmol/L) than women (100.8±33.1) (p<0.0001). Vitamin D supplement users had higher levels of 25(OH)D than nonusers. Mean 25(OH)D levels did not vary by each 5-year age group in either men or women. Only 5 (1.2%) men and 19 (2.9%) women were vitamin D-deficient defined as 25(OH)D <50 nmol/L, while 31 (7.6%) men and 113 (17.2%) women were vitamin D-insufficient. The mean PTH level in the vitamin D-deficient subjects was 63.8±38.3 ng/dL com-pared to 50.5± 25.4 ng/dL in nonvitamin D-deficient subjects. The PTH levels were significantly higher in the vitamin D-deficient compared to the nonvitamin D-deficient subjects (p=0.01). However, there was no statistically significant difference in the proportion of subjects who had hyperparathyroidism (PTH>65 ng/mL).
Except for GS, which was better for men, baseline TCS and TUG measures were similar for men and women. After 2.5 years, the absolute change in GS was the same in both sexes (p=0.4) and the relative difference in GS was −0.76% in women and −0.89% in men (Table 1) . However, the relative decline on the TCS and TUG test was greater in women than men (11% vs. 3% for each test).
In bivariate analyses, lower 25(OH)D levels were associated with female sex and increasing age, higher BMI, and greater alcohol intake. Levels of 25(OH)D were lower in those who did not exercise and in smokers. Lower GS was associated with increased age, alcohol use, and lower BMI. Older age, smoking, and lower baseline physical activity were associated with poorer TUG and TCS.
Association between 25(OH)D levels and physical performance
In cross-sectional analyses, women in the lowest 25(OH)D quartile had the poorest performance on the TUG and TCS tests even after adjusting for age and other confounders ( Table 2 ). Lower extremity function was 7.2% poorer for women in the lowest 25(OH)D quartile (≤80 nmol/L) compared to women in the highest quartile (≥115 nmol/ L). All of the associations were independent of age, BMI, baseline physical activity level, alcohol, estrogen use (in women), and comorbidities including diabetes, hypertension, stroke, coronary artery disease, and congestive heart failure. a TCS is the time (in seconds) it takes to complete five chair stands without stopping or using arms to push off. Increased time to perform these tests reflected poorer physical function b TUG is the amount of time (in seconds) it takes to rise from a chair, walk 3 m, and return to a sitting position. Increased time to perform these tests reflected poorer physical function Prospectively, women in the lowest quartile performed more poorly and had a larger mean percent decrease on the TCS and TUG tests compared to women in the highest 25 (OH)D quartile (20% vs. 8%) ( Table 3) . Women with 25 (OH)D levels ≤80 nmol/L had about threefold greater change in lower extremity physical function compared to women with 25(OH)D levels >80 nmol/L (Fig. 1) .
25(OH)D levels in the lowest quartile (≤80 nmol/L) were associated with lower GS in men at baseline (p value= 0.04), but TCS and TUG was not. However, GS was not associated with 25 To examine the effect of nonparticipation at the follow-up visit on these results, we compared the baseline characteristics of those who did or did not return to the second visit. Table 4 demonstrates that, at baseline, participants who did not return to the clinic were older, thinner with lower 25 (OH)D levels and physical performance compared to participants who were seen at both visits (all comparisons between participants and nonparticipants were statistically significant at the p<0.001 level). Therefore, the magnitude of the associations observed in this study was likely attenuated by the selective attrition of those with lower 25 (OH)D levels and poorer physical function at baseline, a conservative bias. Relatively few participants had missing data for GS (5.3%), TUG (4.5%), or TCS (10.8%). Baseline characteristics were not different between participants with missing data vs. no missing data. Finally, we determined whether impaired renal function explained our findings. Only 56 (5.2%) men and women in this cohort had creatinine clearance less than 30 mg/mL. Results excluding these participants were unchanged.
Discussion
We found a significant cross-sectional association between lower 25(OH)D concentrations and poorer lower extremity function in community-dwelling elderly women. Likewise, low 25(OH)D levels independently predicted the decline in TUG and TCS in women over a 2.5-year follow-up. No associations were observed in men who were less likely than women to have vitamin D insufficiency. The observed associations are likely underestimated, in that they were attenuated by the selective loss of older participants with lower 25(OH)D levels and poorer function at baseline.
Our findings are consistent with other cross-sectional studies. Significant correlations between vitamin D metabolites and leg extension power have been found [26] , as well as with arm muscle strength, ability to climb stairs, physical activity, and the absence of falls [25] . Additionally, circulating calcitriol [1,25(OH) 2 D] has also been positively associated with leg extension power, physical activity, and falls [25] . In another study, both men and women with 25 (OH)D levels less than 40 nmol/L were found to have reduced handgrip strength and walking distance [24] . In addition, effects on gait speed and thigh muscle strength were confirmed in two randomized clinical trials of vitamin D supplements [32, 33] .
Two similar prospective studies of serum 25(OH)D and change in physical function has been published. One study of elderly men and women in the Longitudinal Aging Study Amsterdam showed that adults with serum 25(OH)D up to 50 nmol/L had a higher risk for decline in physical performance over 3 years of follow-up [27] . However, the study by Verrault and colleagues did not find an association between vitamin D deficiency and muscle strength, walking speed, or chair stands. Vitamin D-deficient participants from the Women's Health and Aging Study (WHAS) had an annual 1.17 kg (5.5% compared to baseline) decline in GS and an annual 3.3 s (15.9% compared to baseline) increase in TCS [28] . Women in the RBS had lower rates of functional decline: approximately 0.2 kg (1% compared to baseline) in GS and approximately 0.5 s (4% compared to baseline) on TCS and TUG tests. Result differences between these two cohorts may be explained by the fact that the participants in the WHAS were moderately to severely disabled, unlike the RBS participants who were generally healthy with little to no disabilities. This led the authors to speculate that the WHAS women were already below a threshold of strength where vitamin D could have an impact.
The association between 25(OH)D and physical function in the RBS cohort was observed only in women. This sex difference was unlikely explained by the slightly higher 25 (OH)D levels in men. Selective attrition of men was also unlikely since there were no differences in rates of follow- Change TCS (%) Age-adjusted up or mortality by sex. A more likely explanation is that men retained their strength and had a smaller degree of functional decline compared to women of the same age (3% vs. 11%). RBS men likely had more preserved muscle strength compared to women due to their higher reported physical activity. Other potential mechanisms such as differences in vitamin D receptor gene polymorphisms might also explain the sex-specific differences [37, 38] . There is increasing evidence suggesting that vitamin D intakes higher than those currently recommended are associated with better outcomes. Some suggest that older adults should be supplemented to maintain 25(OH)D levels at a minimum of 70 nmol/L with optimal values between 90 and 100 nmol/L [39] . In this cohort, women with 25(OH)D levels below 80 nmol/L had clinically significant more functional decline. However, levels greater than 80 nmol/L did not confer additional benefit. The vitamin D threshold demonstrated in this study is consistent with previously suggested optimal levels, however, determining the exact level is confounded by assay differences. Recent methodological comparisons have demonstrated that CPBA overestimates 25 (OH)D concentrations compared to radioimmunoassay (RIA) or high protein liquid chromatography (HPLC) [40] . Although the exact levels would differ by assays, methodology differences would not affect the linear association seen between 25 (OH)D with physical function.
Limitations to the present study should be noted. Specifically, the 2.5-year follow-up was a short duration to show a large change in physical function in men. Nevertheless, it was of sufficient duration to show a clinically meaningful loss of function in women. Generalizability is a potential limitation, in that the RBS cohort was largely middle to upper middle class, Caucasian, and lived in a warm sunny climate where outdoor physical activity is almost always possible and where there was a low prevalence of vitamin D deficiency/insufficiency. Any bias should have caused a conservative estimate on the magnitude of the association, as a larger effect would be expected in a population with more vitamin D deficiency. Participation bias likely attenuated the results, since those who did not return to the follow-up evaluation had lower 25(OH)D levels and poorer physical function at baseline. Other residual Comparisons between participants and nonparticipants were statistically significant at the p<0.001 level Fig. 1 The percent change in physical function by quartiles of 25 (OH)D over a 2.5-year follow-up period in older men and women. Physical function were measured by two physical performance tests: timed chair stands (TCS) and timed up and go (TUG). TCS is the time (in seconds) it takes to complete five chair stands without stopping or using arms to push off. TUG is the amount of time (in seconds) it takes to rise from a chair, walk 3 m, and return to a sitting position. Increased time to perform these tests reflected poorer physical performance. Women in the lowest quartile of 25(OH)D had the largest relative increase on the physical function measures confounders and causes of reduced physical function may have contributed to this association. As noted above, differences in 25(OH)D assay methods make it difficult to define optimal levels when comparing results from different studies.
In conclusion, our findings support the hypothesis that 25(OH)D levels are associated with muscle function and support recent data that higher 25(OH)D levels are beneficial for various outcomes. Future studies evaluating different cutpoints with different 25(OH)D assays and longer follow-up are necessary to determine the optimal 25(OH)D level and dose for supplementation.
